Enveda has closed its second $150…
Enveda has closed its second $150 million financing round of [...]
A phase 3 trial of Sanofi’s…
A phase 3 trial of Sanofi’s eczema prospect amlitelimab has [...]
An interim analysis reported in…
An interim analysis reported in June showed that Amgen’s Zai [...]
Gilead Sciences’ Kite Pharma has…
Gilead Sciences’ Kite Pharma has cut off a collaboration with [...]
After becoming the first group to…
After becoming the first group to therapeutically edit human RNA [...]
After throwing down $70 million…
After throwing down $70 million upfront to partner on Black [...]
Boston-based Radiance Biopharma is…
Boston-based Radiance Biopharma is doling out $15 million in cash [...]
Cytokinetics spent Labor Day…
Cytokinetics spent Labor Day weekend in Spain, sharing a big [...]
AstraZeneca’s hypertension pill…
AstraZeneca’s hypertension pill baxdrostat lowered blood pressure by almost 10 [...]
Roche’s hypertension med…
Roche’s hypertension med zilebesiran may have failed to hit the [...]